why do glp 1 agonists cause pancreatitis Does GLP-1 Pancreatitis? Risk Factors Explained GLP-1 agonists-induced autoimmune pancreatitis |

White WB, Cannon CP, Heller SR, et al

but simply to discuss some of the science behind the impact of a class of drugs designed to slow gut motility on already sensitive digestive systems

The GLP-1 agonists market report provides insights around existing treatment practices in patients with Glucagon-like Peptide-1 (GLP-1) Agonists, approved (if any) and emerging Glucagon-like Peptide-1 (GLP-1) Agonists, market share of individual therapies, patient pool eligible for treatment with Glucagon-like Peptide-1 (GLP-1) Agonists, along with current and forecasted 7MM Glucagon-like Peptide-1 (GLP-1) Agonists market size from 2020-2034 by therapies and by indication

Nat Rev Endocrinol 8 , 728742 (2012)

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

Kanoski et al., 2011